Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05435989 · ClinicalTrials.gov registry record · NA
Extended High-frequency Hearing and Speech Perception
A NA study of Low-pass Filtering Speech, sponsored by Brian Monson.
- Recruiting
- Registry status
- NA
- Development phase
- 480
- Enrollment target
- 1
- Study location
NCT05435989: Recruiting NA study of Low-pass Filtering Speech, sponsored by Brian Monson.
NCT05435989 is a NA study of Low-pass Filtering Speech that is actively recruiting participants, run by Brian Monson. The registered enrollment target is 480 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05435989, a NA study of Low-pass Filtering Speech, is actively recruiting participants, sponsored by Brian Monson.
- RECRUITING
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the effects of low-pass filtering speech on speech perception.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Reduced extended high-frequency audibility
Study Locations (1)
Illinois
- University of Illinois Urbana-Champaign - Champaign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT05435989 shows while recruiting
NCT05435989 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Low-pass Filtering Speech appearing as the primary indexed condition, and to 1 intervention - of which Reduced extended high-frequency audibility is the first listed.
NCT05435989 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05435989 about?
NCT05435989 is a clinical study titled "Extended High-frequency Hearing and Speech Perception". This study examines the effects of low-pass filtering speech on speech perception.
What is the current status of trial NCT05435989?
This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2021-11-09. Estimated completion is 2026-06.
What conditions does trial NCT05435989 study?
This clinical trial studies the following conditions: Low-pass Filtering Speech.
What interventions are being tested in trial NCT05435989?
The interventions under investigation include: Reduced extended high-frequency audibility (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05435989?
This trial is sponsored by Brian Monson, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05435989 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05435989's enrollment target sits among peer trials
480 216th of 2000 higher than 1,783 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI